Viewing StudyNCT04676516



Ignite Creation Date: 2024-05-06 @ 3:34 PM
Last Modification Date: 2024-10-26 @ 1:52 PM
Study NCT ID: NCT04676516
Status: COMPLETED
Last Update Posted: 2022-10-25
First Post: 2020-07-28

Brief Title: A Phase II Window of Opportunity Trial of PRMT5 Inhibitor GSK3326595 in Early Stage Breast Cancer
Sponsor: Ottawa Hospital Research Institute
Organization: Ottawa Hospital Research Institute

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Hormone Receptor HR positive breast cancer View
Window of Opportunity View
PRMT5 inhibitor View
GSK3326595 View
Early Stage Breast Cancer View